MabionCD20
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MabionCD20, covering 2020-05-14 to 2023-10-25. Get the full timeline:
Most recent: Clinical Trial Update: MabionCD20 Compared to MabThera in Lymphoma Patients [Phase 3]